UniProt ID | LBR_HUMAN | |
---|---|---|
UniProt AC | Q14739 | |
Protein Name | Lamin-B receptor | |
Gene Name | LBR | |
Organism | Homo sapiens (Human). | |
Sequence Length | 615 | |
Subcellular Localization |
Nucleus inner membrane Multi-pass membrane protein. |
|
Protein Description | Anchors the lamina and the heterochromatin to the inner nuclear membrane.. | |
Protein Sequence | MPSRKFADGEVVRGRWPGSSLYYEVEILSHDSTSQLYTVKYKDGTELELKENDIKPLTSFRQRKGGSTSSSPSRRRGSRSRSRSRSPGRPPKSARRSASASHQADIKEARREVEVKLTPLILKPFGNSISRYNGEPEHIERNDAPHKNTQEKFSLSQESSYIATQYSLRPRREEVKLKEIDSKEEKYVAKELAVRTFEVTPIRAKDLEFGGVPGVFLIMFGLPVFLFLLLLMCKQKDPSLLNFPPPLPALYELWETRVFGVYLLWFLIQVLFYLLPIGKVVEGTPLIDGRRLKYRLNGFYAFILTSAVIGTSLFQGVEFHYVYSHFLQFALAATVFCVVLSVYLYMRSLKAPRNDLSPASSGNAVYDFFIGRELNPRIGTFDLKYFCELRPGLIGWVVINLVMLLAEMKIQDRAVPSLAMILVNSFQLLYVVDALWNEEALLTTMDIIHDGFGFMLAFGDLVWVPFIYSFQAFYLVSHPNEVSWPMASLIIVLKLCGYVIFRGANSQKNAFRKNPSDPKLAHLKTIHTSTGKNLLVSGWWGFVRHPNYLGDLIMALAWSLPCGFNHILPYFYIIYFTMLLVHREARDEYHCKKKYGVAWEKYCQRVPYRIFPYIY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Ubiquitination | ---MPSRKFADGEVV ---CCCCCCCCCCEE | 49.60 | 24816145 | |
13 | Methylation | FADGEVVRGRWPGSS CCCCCEECCCCCCCC | 33.85 | 115481893 | |
20 | Phosphorylation | RGRWPGSSLYYEVEI CCCCCCCCCEEEEEE | 26.72 | - | |
22 | Phosphorylation | RWPGSSLYYEVEILS CCCCCCCEEEEEEEE | 10.26 | - | |
23 | Phosphorylation | WPGSSLYYEVEILSH CCCCCCEEEEEEEEC | 20.84 | - | |
29 | Phosphorylation | YYEVEILSHDSTSQL EEEEEEEECCCCCCE | 30.80 | 28122231 | |
32 | Phosphorylation | VEILSHDSTSQLYTV EEEEECCCCCCEEEE | 25.24 | 28122231 | |
33 | Phosphorylation | EILSHDSTSQLYTVK EEEECCCCCCEEEEE | 26.92 | 28122231 | |
33 | O-linked_Glycosylation | EILSHDSTSQLYTVK EEEECCCCCCEEEEE | 26.92 | 28510447 | |
34 | Phosphorylation | ILSHDSTSQLYTVKY EEECCCCCCEEEEEE | 23.34 | 28122231 | |
34 | O-linked_Glycosylation | ILSHDSTSQLYTVKY EEECCCCCCEEEEEE | 23.34 | 28510447 | |
37 | Phosphorylation | HDSTSQLYTVKYKDG CCCCCCEEEEEECCC | 11.23 | 28122231 | |
38 | Phosphorylation | DSTSQLYTVKYKDGT CCCCCEEEEEECCCC | 21.08 | 28122231 | |
42 | 2-Hydroxyisobutyrylation | QLYTVKYKDGTELEL CEEEEEECCCCEEEE | 43.92 | - | |
42 | Ubiquitination | QLYTVKYKDGTELEL CEEEEEECCCCEEEE | 43.92 | 33845483 | |
42 | Acetylation | QLYTVKYKDGTELEL CEEEEEECCCCEEEE | 43.92 | 26051181 | |
50 | Ubiquitination | DGTELELKENDIKPL CCCEEEEECCCCCCC | 45.13 | 32015554 | |
50 | Acetylation | DGTELELKENDIKPL CCCEEEEECCCCCCC | 45.13 | 26051181 | |
55 | Acetylation | ELKENDIKPLTSFRQ EEECCCCCCCCCCCC | 36.52 | 19608861 | |
55 | Malonylation | ELKENDIKPLTSFRQ EEECCCCCCCCCCCC | 36.52 | 26320211 | |
55 | Ubiquitination | ELKENDIKPLTSFRQ EEECCCCCCCCCCCC | 36.52 | 19608861 | |
58 | Phosphorylation | ENDIKPLTSFRQRKG CCCCCCCCCCCCCCC | 34.05 | 23401153 | |
59 | Phosphorylation | NDIKPLTSFRQRKGG CCCCCCCCCCCCCCC | 26.56 | 30266825 | |
67 | Phosphorylation | FRQRKGGSTSSSPSR CCCCCCCCCCCCCCC | 33.51 | 28176443 | |
68 | Phosphorylation | RQRKGGSTSSSPSRR CCCCCCCCCCCCCCC | 35.58 | 20363803 | |
69 | Phosphorylation | QRKGGSTSSSPSRRR CCCCCCCCCCCCCCC | 30.43 | 20363803 | |
70 | Phosphorylation | RKGGSTSSSPSRRRG CCCCCCCCCCCCCCC | 46.48 | 30278072 | |
71 | Phosphorylation | KGGSTSSSPSRRRGS CCCCCCCCCCCCCCC | 27.02 | 30278072 | |
73 | Phosphorylation | GSTSSSPSRRRGSRS CCCCCCCCCCCCCCC | 40.13 | 28176443 | |
78 | Phosphorylation | SPSRRRGSRSRSRSR CCCCCCCCCCCCCCC | 25.85 | 20068231 | |
80 | Phosphorylation | SRRRGSRSRSRSRSP CCCCCCCCCCCCCCC | 35.98 | 20068231 | |
82 | Phosphorylation | RRGSRSRSRSRSPGR CCCCCCCCCCCCCCC | 35.54 | 30576142 | |
84 | Phosphorylation | GSRSRSRSRSPGRPP CCCCCCCCCCCCCCC | 38.05 | 22167270 | |
86 | Phosphorylation | RSRSRSRSPGRPPKS CCCCCCCCCCCCCHH | 32.71 | 30266825 | |
93 | Phosphorylation | SPGRPPKSARRSASA CCCCCCHHHHHHCCH | 32.55 | 30576142 | |
97 | Phosphorylation | PPKSARRSASASHQA CCHHHHHHCCHHHHH | 22.48 | 22167270 | |
99 | Phosphorylation | KSARRSASASHQADI HHHHHHCCHHHHHHH | 31.39 | 22167270 | |
101 | Phosphorylation | ARRSASASHQADIKE HHHHCCHHHHHHHHH | 17.40 | 23927012 | |
107 | Acetylation | ASHQADIKEARREVE HHHHHHHHHHHHHCC | 45.96 | 7672315 | |
107 | Ubiquitination | ASHQADIKEARREVE HHHHHHHHHHHHHCC | 45.96 | 23000965 | |
107 | 2-Hydroxyisobutyrylation | ASHQADIKEARREVE HHHHHHHHHHHHHCC | 45.96 | - | |
116 | Ubiquitination | ARREVEVKLTPLILK HHHHCCEEEEEEEEC | 32.89 | 22817900 | |
118 | Phosphorylation | REVEVKLTPLILKPF HHCCEEEEEEEECCC | 15.44 | 30266825 | |
123 | Ubiquitination | KLTPLILKPFGNSIS EEEEEEECCCCCCHH | 31.16 | 23000965 | |
123 | Methylation | KLTPLILKPFGNSIS EEEEEEECCCCCCHH | 31.16 | 70991 | |
123 | Acetylation | KLTPLILKPFGNSIS EEEEEEECCCCCCHH | 31.16 | 23236377 | |
128 | Phosphorylation | ILKPFGNSISRYNGE EECCCCCCHHHCCCC | 23.48 | 30266825 | |
130 | Phosphorylation | KPFGNSISRYNGEPE CCCCCCHHHCCCCHH | 28.65 | 30266825 | |
132 | Phosphorylation | FGNSISRYNGEPEHI CCCCHHHCCCCHHHH | 22.26 | 26074081 | |
147 | Ubiquitination | ERNDAPHKNTQEKFS CCCCCCCCCHHHCCC | 61.71 | 29967540 | |
154 | Phosphorylation | KNTQEKFSLSQESSY CCHHHCCCCCHHHHH | 37.87 | 30576142 | |
156 | Phosphorylation | TQEKFSLSQESSYIA HHHCCCCCHHHHHHH | 30.61 | 30108239 | |
159 | Phosphorylation | KFSLSQESSYIATQY CCCCCHHHHHHHHHC | 22.32 | 28152594 | |
160 | Phosphorylation | FSLSQESSYIATQYS CCCCHHHHHHHHHCC | 21.58 | 28152594 | |
161 | Phosphorylation | SLSQESSYIATQYSL CCCHHHHHHHHHCCC | 12.12 | 28152594 | |
164 | Phosphorylation | QESSYIATQYSLRPR HHHHHHHHHCCCCCC | 20.62 | 28152594 | |
166 | Phosphorylation | SSYIATQYSLRPRRE HHHHHHHCCCCCCCH | 12.81 | 28152594 | |
167 | Phosphorylation | SYIATQYSLRPRREE HHHHHHCCCCCCCHH | 14.21 | 28152594 | |
176 | Ubiquitination | RPRREEVKLKEIDSK CCCCHHCCHHCCCCH | 58.06 | - | |
178 | Ubiquitination | RREEVKLKEIDSKEE CCHHCCHHCCCCHHH | 47.08 | 27667366 | |
182 | Phosphorylation | VKLKEIDSKEEKYVA CCHHCCCCHHHHHHH | 47.86 | 30108239 | |
183 | Acetylation | KLKEIDSKEEKYVAK CHHCCCCHHHHHHHH | 67.17 | 23749302 | |
183 | Ubiquitination | KLKEIDSKEEKYVAK CHHCCCCHHHHHHHH | 67.17 | 33845483 | |
186 | Ubiquitination | EIDSKEEKYVAKELA CCCCHHHHHHHHHHH | 46.23 | 23000965 | |
187 | Phosphorylation | IDSKEEKYVAKELAV CCCHHHHHHHHHHHH | 14.66 | - | |
190 | Acetylation | KEEKYVAKELAVRTF HHHHHHHHHHHHCEE | 43.12 | 19608861 | |
190 | Ubiquitination | KEEKYVAKELAVRTF HHHHHHHHHHHHCEE | 43.12 | 23000965 | |
190 | 2-Hydroxyisobutyrylation | KEEKYVAKELAVRTF HHHHHHHHHHHHCEE | 43.12 | - | |
196 | Phosphorylation | AKELAVRTFEVTPIR HHHHHHCEEEECEEE | 19.97 | 30266825 | |
200 | Phosphorylation | AVRTFEVTPIRAKDL HHCEEEECEEEHHHC | 13.05 | 30266825 | |
284 | Phosphorylation | IGKVVEGTPLIDGRR CCCCCCCCCCCCCCE | 11.04 | - | |
357 | Phosphorylation | KAPRNDLSPASSGNA CCCCCCCCCCCCCCC | 22.68 | 21712546 | |
360 | Phosphorylation | RNDLSPASSGNAVYD CCCCCCCCCCCCCEE | 42.01 | 21712546 | |
361 | Phosphorylation | NDLSPASSGNAVYDF CCCCCCCCCCCCEEE | 37.87 | 21712546 | |
366 | Phosphorylation | ASSGNAVYDFFIGRE CCCCCCCEEEEECCC | 12.48 | 27642862 | |
380 | Phosphorylation | ELNPRIGTFDLKYFC CCCCCCCEECHHHHH | 16.17 | - | |
385 | Phosphorylation | IGTFDLKYFCELRPG CCEECHHHHHHCCCH | 22.28 | - | |
466 | Ubiquitination | GDLVWVPFIYSFQAF CCEEEHHHEEEEEEE | 6.24 | 24816145 | |
498 | Phosphorylation | IVLKLCGYVIFRGAN HHHHHHCHHHHCCCC | 6.86 | 30108239 | |
508 | Ubiquitination | FRGANSQKNAFRKNP HCCCCHHHCCCCCCC | 50.49 | 24816145 | |
516 | Phosphorylation | NAFRKNPSDPKLAHL CCCCCCCCCHHHHHC | 75.77 | 29214152 | |
519 | Ubiquitination | RKNPSDPKLAHLKTI CCCCCCHHHHHCEEE | 64.40 | 29967540 | |
524 | Ubiquitination | DPKLAHLKTIHTSTG CHHHHHCEEEECCCC | 35.25 | 32015554 | |
525 | Phosphorylation | PKLAHLKTIHTSTGK HHHHHCEEEECCCCC | 25.09 | 27080861 | |
528 | Phosphorylation | AHLKTIHTSTGKNLL HHCEEEECCCCCCEE | 24.92 | 27080861 | |
530 | Phosphorylation | LKTIHTSTGKNLLVS CEEEECCCCCCEEEE | 54.02 | 27080861 | |
532 | Ubiquitination | TIHTSTGKNLLVSGW EEECCCCCCEEEECE | 44.50 | - | |
559 | Ubiquitination | LIMALAWSLPCGFNH HHHHHHHHCCCCCHH | 19.47 | 23000965 | |
593 | Acetylation | RDEYHCKKKYGVAWE HHHHHHHCHHCCCHH | 57.53 | 25953088 | |
593 | Ubiquitination | RDEYHCKKKYGVAWE HHHHHHHCHHCCCHH | 57.53 | 29967540 | |
594 | Ubiquitination | DEYHCKKKYGVAWEK HHHHHHCHHCCCHHH | 32.50 | 19608861 | |
594 | Malonylation | DEYHCKKKYGVAWEK HHHHHHCHHCCCHHH | 32.50 | 26320211 | |
594 | Acetylation | DEYHCKKKYGVAWEK HHHHHHCHHCCCHHH | 32.50 | 19608861 | |
594 | 2-Hydroxyisobutyrylation | DEYHCKKKYGVAWEK HHHHHHCHHCCCHHH | 32.50 | - | |
601 | Ubiquitination | KYGVAWEKYCQRVPY HHCCCHHHHHHCCCC | 40.39 | 23000965 | |
601 | Methylation | KYGVAWEKYCQRVPY HHCCCHHHHHHCCCC | 40.39 | 19608861 | |
601 | Malonylation | KYGVAWEKYCQRVPY HHCCCHHHHHHCCCC | 40.39 | 26320211 | |
601 | Acetylation | KYGVAWEKYCQRVPY HHCCCHHHHHHCCCC | 40.39 | 19608861 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LBR_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LBR_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CBX3_HUMAN | CBX3 | physical | 8663349 | |
CBX5_HUMAN | CBX5 | physical | 8663349 | |
MECP2_HUMAN | MECP2 | physical | 19331822 | |
CBX5_HUMAN | CBX5 | physical | 15882967 | |
H31_HUMAN | HIST1H3A | physical | 22052904 | |
MD2BP_HUMAN | MAD2L1BP | physical | 28514442 | |
ZN579_HUMAN | ZNF579 | physical | 28514442 | |
CHTOP_HUMAN | CHTOP | physical | 28514442 | |
PSMD3_HUMAN | PSMD3 | physical | 28031328 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00234 | Pelger-Huet anomaly | |||||
H00447 | HEM skeletal dysplasia; Greenberg dysplasia | |||||
H01133 | Reynolds syndrome | |||||
OMIM Disease | ||||||
169400 | Pelger-Huet anomaly (PHA) | |||||
215140 | Greenberg dysplasia (GRBGD) | |||||
613471 | Reynolds syndrome (REYNS) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-55; LYS-190; LYS-594 ANDLYS-601, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Temporal control of nuclear envelope assembly by phosphorylation oflamin B receptor."; Tseng L.C., Chen R.H.; Mol. Biol. Cell 22:3306-3317(2011). Cited for: PHOSPHORYLATION AT SER-71 AND SER-86 BY CDK1. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-118, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-118, AND MASSSPECTROMETRY. |